MedPath

Promoting Healthy Brain Development: Wellness for 2 Study

Not Applicable
Completed
Conditions
Prenatal Stress
Interventions
Behavioral: Mothers and Babies (MB) Course
Behavioral: Just in Time Intervention (JITI) Content
Device: Biostamp nPoint Device
Registration Number
NCT05052281
Lead Sponsor
Northwestern University
Brief Summary

The "Promoting Healthy Brain Project" (PHBP) is part of the Lurie Children's Hospital Strategic Research Initiative on Perinatal Origins of Childhood Disease: Research \& Prevention at the Maternal-Fetal Interface. The overall purpose of the PHBP is to test whether reducing maternal stress during pregnancy is associated with improved neurodevelopment in the first year of life. This will be tested via a randomized controlled trial (n = 100) of a technology and mindfulness enhanced prenatal stress-reduction intervention (Mothers and Babies; MB).

Detailed Description

The "Promoting Healthy Brain Project" (PHBP) aims to improve infant neurodevelopmental trajectories by intervening on the fetal environment. The PHBP will experimentally test whether reducing prenatal maternal stress is associated with improved neurodevelopment in the first year of life. A randomized controlled trial (RCT) of a technology and mindfulness-enhanced prenatal maternal stress-reduction intervention (The Mothers and Babies Course; MB), compared to usual prenatal care. Prospective evaluation of infant neurodevelopmental outcomes will take place through infant age 24 months. Participants assigned to the intervention group will be offered the 12-session MB intervention, a well-studied intervention that will include new mindfulness practice enhancements designed to promote practice of awareness and attention to the present moment. MB visits will be delivered 1-on-1 by a trained facilitator in an open and nonjudgmental way, and will be offered in-person, over the phone, and/or by video chat. Throughout the intervention, all participants (intervention group and control group) will also wear a wireless, "smart" health sensing device (BioStamp Sensor - nPoint Device) that will measure heart rate and motion. Mothers' heart rate variability and self-reported stress and emotion will be monitored using the BioStamp Sensor and brief smartphone surveys. For mothers in the intervention group, patterns of prolonged stress will trigger a "just-in-time adapted intervention" (JITAI) that will be delivered to mothers' smartphones. The booster intervention will include activities that will enhance skills learned in the MB course. All participants will complete self-report measures of prenatal maternal stress, emotion, depression, and skills related to the intervention (e.g., mindfulness). Infant neurodevelopmental health will be measured via brain and behavioral indicators of self-regulation, including performance-based indicators of executive function and corollary prefrontal cortex maturation and dimensional phenotypes of disruptive behavior, particularly irritability.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • ≥ 18 years old;
  • enrolled under 22 weeks gestation;
  • receiving prenatal care from a Northwestern University prenatal care clinic & planning to deliver at Northwestern Hospitals;
  • English-speaking
  • Participants must own a smartphone and be must be willing to receive text messages and respond to short online surveys using their smartphone.
  • Eligible participants must also agree to wear a wireless adhesive sensor, the BioStamp, daily, throughout the 12-week MB course.
  • Eligible participants will also have WiFi internet access for the duration of their participation in the study, in order to complete online questionnaires and upload sensor data.
  • Eligible participants must also agree to have their child participate in the neurodevelopmental assessments from birth-12 months.
Exclusion Criteria
  • Women will be ineligible to participate in this study if they have known pregnancy or chronic medical complications that may place their infant at risk for neurological disorders (e.g., HIV; acute cytomegalovirus infection (CMV); toxoplasmosis; zika virus; Phenylketonuria (PKU); chromosomal anomalies; metabolic disorder; substance use disorders) or significant mental health disorders (e.g., schizophrenia, bipolar disorder, psychosis) which could interfere with study adherence.
  • Participants unable to wear the BioStamp Sensor due to known skin sensitivity (e.g., allergy to adhesives or silicone), current skin irritation, or broken skin at the placement site will not be eligible to participate.
  • Participants with a pacemaker or other sensitive medical device will be excluded.
  • Women will not be eligible to participate if unable to provide informed consent, complete MB sessions, or complete study assessments in English.
  • Women who are currently participating in an MB course at the time of recruitment will not be eligible to participate.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupJust in Time Intervention (JITI) ContentThe first MB course session and technology training will take place in-person, prior to 23 weeks gestation. The Mothers and Babies course (MB) is a 12-session manualized stress-reduction intervention that will be delivered to participants, prenatally, with an integrated technology suite designed for timely detection and response to maternal stress. Sessions are delivered 1-on-1 with a trained facilitator and are based on principles of cognitive-behavioral therapy (CBT) and attachment theory. The MB course is divided into 3 sections: 1) Pleasant Activities; 2) Thoughts; 3) Contact with Others. Throughout each module, mindfulness skills training will be integrated as a strategy to help "center" participants. All participants will receive a Participant Manual for Families, containing worksheets that correspond to the 12 sessions.
Intervention groupMothers and Babies (MB) CourseThe first MB course session and technology training will take place in-person, prior to 23 weeks gestation. The Mothers and Babies course (MB) is a 12-session manualized stress-reduction intervention that will be delivered to participants, prenatally, with an integrated technology suite designed for timely detection and response to maternal stress. Sessions are delivered 1-on-1 with a trained facilitator and are based on principles of cognitive-behavioral therapy (CBT) and attachment theory. The MB course is divided into 3 sections: 1) Pleasant Activities; 2) Thoughts; 3) Contact with Others. Throughout each module, mindfulness skills training will be integrated as a strategy to help "center" participants. All participants will receive a Participant Manual for Families, containing worksheets that correspond to the 12 sessions.
Intervention groupBiostamp nPoint DeviceThe first MB course session and technology training will take place in-person, prior to 23 weeks gestation. The Mothers and Babies course (MB) is a 12-session manualized stress-reduction intervention that will be delivered to participants, prenatally, with an integrated technology suite designed for timely detection and response to maternal stress. Sessions are delivered 1-on-1 with a trained facilitator and are based on principles of cognitive-behavioral therapy (CBT) and attachment theory. The MB course is divided into 3 sections: 1) Pleasant Activities; 2) Thoughts; 3) Contact with Others. Throughout each module, mindfulness skills training will be integrated as a strategy to help "center" participants. All participants will receive a Participant Manual for Families, containing worksheets that correspond to the 12 sessions.
Stress monitoring (control) groupBiostamp nPoint DeviceThis group will not receive any additional intervention but will engage in stress monitoring via biosensors and EMA text messages through the 14 week period
Primary Outcome Measures
NameTimeMethod
Disruptive Behavior Diagnostic Observation Schedule (DB DOS)12 months, 24 months

The DB DOS is a standardized observation of infant arousal, soothability, reactivity, and temper loss. During early infancy, the

MAP-DB1 month, 7 months, 12 months, 24 months

Parent report measure of infant irritability.

State Trait Anxiety Inventory (STAI)Prenatal, 1 month, 3 months, 7 months, 12 months, 24 months

The STAI is a 40 item self report questionnaire that assesses both state anxiety and trait anxiety.

Perceived Stress Scale (PSS)Prenatal, 1 month, 3 months, 7 months, 12 months, 24 months

The PSS is a self-report measure of the degree to which an individual perceives their life situations to be stressful. The instrument includes 10 items that assess how unpredictable, uncontrollable, and overloaded respondents find their lives, and assess current levels of experienced stress.

PROMIS DepressionPrenatal, 1 month, 3 months, 7 months, 12 months, 24 months

Mothers complete a 28-item scale that assesses depressive symptoms experienced in the past 7 days.

Secondary Outcome Measures
NameTimeMethod
Five Facet Mindfulness Questionnaire (FFMQ)Prenatal, 1 month, 3 months, 7 months, 12 months, 24 months

The FFMQ is a 39-item self report survey that taps into five areas of mindfulness, including observation, description, aware actions, non-judgmental inner experience, and non-reactivity.

Alberta Infant Motor Scale (AIMS)1 month

The Alberta Infant Motor Scale (AIMS) is a 10-20 minute norm referenced, standardized, gross motor assessment. Infants are observed in four positions: prone, sitting, supine, and standing. For each subscale, items are scored as "observed" or "not observed". A total raw score and percentile are calculated.

BirthweightBirth

Infant birthweight will be obtained from EHR data collected at the hospital at birth

Brief Infant Toddler Social Emotional Assessment (BITSEA)12 months, 24 months

Parent report measure of behavior problems and social competencies in children ages 1-3 that identifies delays or deficits in areas of social-emotional development.

Parenting Stress Index (PSI) - Role Restriction Subscale3 months, 7 months, 12 months, 24 months

The PSI Role Restriction subscale includes 7 mother-report items regarding her feelings of limited freedom and restriction of her identity to the parenting role.

Maternal Heart Rate VariabilityPregnancy (duration 14 weeks)

variability/physiological stress as indicated by a machine learned model applied to electrocardiogram (ECG) signals.

Inflammatory and neuroimmune biomarkersAt birth

Placenta and cord blood will be collected at birth. Tests to be performed on these samples include measurement of inflammatory markers related to stress, such as a multiplex immunoassay panel of the following cytokines and chemokines: (IL-6, IL-8, IL-10, C-reactive protein, TNF-alpha, TGF-beta, IL-1beta, procalcitonin, cortisol).

ERP mean amplitude1 month, 12 months, 24 months

The baby will complete a baseline or resting EEG for 2-5 minutes and then hear an auditory oddball paradigm with speech syllables while resting for \~10 min. ERP (event related potential) mean amplitude will be measured as a marker of infant neurodevelopment.

Bayley Scales of Infant Development7 months, 12 months, 24 months

The Bayley Scales of Infant and Toddler Development Fourth Edition (Bayley-4) is a five-domain assessment tool used to determine developmental delays in children. The developmental domains are cognitive, language, motor, social-emotional, and adaptive behavior, and include direct assessment of the child and parent report.

Preschool Age Psychiatric Assessment (PAPA)24 months

Parent structured interview for diagnosing psychiatric disorders in children ages 2-5.

NICU Neonatal Behavioral Scale (NNNS)1 month

The NNNS is an assessment of neurobehavioral organization, neurological reflexes, motor development - active and passive tone, and signs of stress and withdrawal in neonates, developed for use with at-risk or drug-exposed infants but has been normed with typically developing infants.

General Movements Assessment (GMA)1 month

General movements are a developmentally regulated pattern of spontaneous motor activity. By 10-15 weeks of age, the predominant general movements seen are called Fidgety Movements - a pattern of continuous, small amplitude movements of the neck, trunk and limbs during wakefulness that disappear with agitation. These patterns are identifiable and are classified as normal if present (intermittent or continual), and abnormal if exaggerated (with respect to speed and amplitude), sporadic (interspersed with long pauses) or absent. Babies are observed for up to 30 minutes in a supine position to assess for spontaneous movements.

Infant Behavior Questionnaire-Revised (IBQ-R) short form1 month, 7 months, 12 months

The IBQ-R is a parent-report survey designed to measure multiple dimensions of temperament in infants up to age 12 months.

Behavioral Activation Depression Scale (BADS) - short formprenatal, 3 months, 7 months, 12 months, 24 months

Self-report 9-item measure of behaviors that indicate depression and can be targeted for change by cognitive behavioral therapy and behavior activation. Mothers complete this measure regarding behaviors experienced over the past week.

Negative Mood Regulation Scale (NMRS)prenatal, 3 months, 7 months, 12 months, 24 months

This self-report, 30-item scale measures expectancies and beliefs that the mothers have regarding their abilities to alleviate their negative mood, anger, anxiety and depression.

Maternal Infant Responsiveness Instrument (MIRI)1 month, 7 months, 12 months

The MIRI is a 22 item questionnaire designed to assess a mother's feelings about her infant, her recognition of her responsiveness to the infant, and her infants responses.

Early Childhood Irritability Related Impairment Interview (E-CRI)24 months

The E-CRI is a semi-structured interview designed to measure early childhood impairment resulting from young children's tantrums and irritability across various contexts.

Perceived Stress Scale (PSS)1 month, 3 months, 7 months, 12 months, 24 months

Self-report measure of the degree to which an individual perceives their life situations to be stressful. The instrument includes 10 items that assess how unpredictable, uncontrollable, and overloaded respondents find their lives, and assess current levels of experienced stress.

Parental Cognitions and Conduct Toward the Infant Scale (PACOTIS)1 month, 3 months, 7 months, and 12 months

The PACOTIS is a mother report measure of their actions, thoughts, and feelings during interactions with their baby.

Test of Infant Motor Performance (TIMP)1 month

The TIMP is a norm-referenced measure designed to evaluate motor control and organization of posture and movement for functional activities in infants 32 weeks gestational age to four months post-term age and measures both spontaneous behaviors and elicited items.

Prefrontal cortex thickness1 month, 12 months, 24 months

Cortical thickness and surface area of pre-frontal cortex regions, which have been linked to child irritability and Infant dysregulation, is measured through natural sleep MRI.

EEG power1 month, 12 months, 24 months

The baby will complete a baseline or resting EEG for 2-5 minutes and then hear an auditory oddball paradigm with speech syllables while resting for \~10 min. EEG (electroencephalogram) power will be measured as a marker infant neurodevelopment.

Medical Outcomes Study (MOS) Social Support SurveyPrenatal, 3 months, 7 months, 12 months, 24 months

The MOS Social Support Survey is a 19-item self-report measure of the mother's availability of social support in a variety of domains including emotional support, tangible support, affectionate support, and positive social interaction.

MacArthur-Bates Communicative Development Inventories (MCDI)12 months, 24 months

The MCDI is a parent-report questionnaire about their child's communication and language development. The Words \& Gestures form is used at 12 months and the Words \& Sentences form is used at 24 months.

Trial Locations

Locations (2)

Northwestern University (Feinberg School of Medicine)

🇺🇸

Chicago, Illinois, United States

Ann & Robert H. Lurie Children's Hospital of Chicago

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath